Extended Data Fig. 8: Pro-survival effect by monoclonal antibodies against PD-L1 in GL261 mouse GBM model.

a, Experimental timeline for studying the effect of PD-L1 mAB in the GL261 GBM model. A large dose of PD-L1 mAB (339.6A2, mouse IgG1, κ; 2.25 mg in total) was administered. b, Kaplan–Meier survival curves showing survival outcome of PD-L1 mAB or control in the GL261 GBM model. n = 6 each group, Log-rank test used to define statistical significance.